Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Morimoto

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 10, 2002
Contrast-enhanced sonography of small pancreatic mass lesionsYutaka Ozawa, Kazushi Numata, Katsuaki Tanaka, et al.
Gastrointestinal Endoscopy|October 22, 2011
Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissectionKingo Hirasawa, Atsushi Kokawa, Hiroyuki Oka, et al.
International Journal of Clinical Oncology|August 18, 2011
Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrationsManabu Morimoto, Kazushi Numata, Akito Nozaki, et al.
BMC Research Notes|October 28, 2015
Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinomaJuichi Takada, Hisashi Hidaka, Takahide Nakazawa, et al.
Langenbeck'S Archives of Surgery|February 26, 2022
Postoperative acute pancreatitis after pancreatic resection in patients with pancreatic ductal adenocarcinomaMasaaki Murakawa, Yuto Kamioka, Shinnosuke Kawahara, et al.
Hepatology (Baltimore, Md.)|May 25, 2002
Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periodsManabu Morimoto, Kazuya Sugimori, Kazuhito Shirato, et al.
Investigational New Drugs|December 5, 2018
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumorsToshihiko Doi, Kiyotaka Yoh, Kohei Shitara, et al.
European Journal of Radiology|June 18, 2013
Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinomaKenichi Takizawa, Kazushi Numata, Manabu Morimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 14, 2012
[Influence of body surface area on efficacy and safety of sorafenib in advanced hepatocellular carcinoma]Satoshi Kobayashi, Shinichi Ohkawa, Masaaki Kondo, et al.
Journal of Cancer|February 6, 2019
The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resectionMasaaki Murakawa, Toru Aoyama, Yohei Miyagi, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 10, 2002
Contrast-enhanced sonography of small pancreatic mass lesionsYutaka Ozawa, Kazushi Numata, Katsuaki Tanaka, et al.
Gastrointestinal Endoscopy|October 22, 2011
Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissectionKingo Hirasawa, Atsushi Kokawa, Hiroyuki Oka, et al.
International Journal of Clinical Oncology|August 18, 2011
Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrationsManabu Morimoto, Kazushi Numata, Akito Nozaki, et al.
BMC Research Notes|October 28, 2015
Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinomaJuichi Takada, Hisashi Hidaka, Takahide Nakazawa, et al.
Langenbeck'S Archives of Surgery|February 26, 2022
Postoperative acute pancreatitis after pancreatic resection in patients with pancreatic ductal adenocarcinomaMasaaki Murakawa, Yuto Kamioka, Shinnosuke Kawahara, et al.
Hepatology (Baltimore, Md.)|May 25, 2002
Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periodsManabu Morimoto, Kazuya Sugimori, Kazuhito Shirato, et al.
Investigational New Drugs|December 5, 2018
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumorsToshihiko Doi, Kiyotaka Yoh, Kohei Shitara, et al.
European Journal of Radiology|June 18, 2013
Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinomaKenichi Takizawa, Kazushi Numata, Manabu Morimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 14, 2012
[Influence of body surface area on efficacy and safety of sorafenib in advanced hepatocellular carcinoma]Satoshi Kobayashi, Shinichi Ohkawa, Masaaki Kondo, et al.
Journal of Cancer|February 6, 2019
The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resectionMasaaki Murakawa, Toru Aoyama, Yohei Miyagi, et al.
Pageof 16